Patents by Inventor Joseph T. Nickels, JR.

Joseph T. Nickels, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL
    Publication number: 20180010127
    Abstract: The present invention provides a method of quantifying miR-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating miR-185 in regulating LDL and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/LDL related cardiovascular diseases in humans.
    Type: Application
    Filed: July 11, 2017
    Publication date: January 11, 2018
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Muhua Yang, Joseph T. Nickels, JR., Weidong Liu, Christina Ann Pellicane
  • Method of enhancing miR-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
    Patent number: 9243250
    Abstract: The present invention provides a method of quantifying miR-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating miR-185 in regulating LDL and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/LDL related cardiovascular diseases in humans.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: January 26, 2016
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Muhua Yang, Joseph T Nickels, Jr., Weidong Liu, Christina Ann Pellicane
  • A METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL
    Publication number: 20130337459
    Abstract: The present invention provides a method of quantifying miR-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating miR-185 in regulating LDL and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/LDL related cardiovascular diseases in humans.
    Type: Application
    Filed: June 17, 2013
    Publication date: December 19, 2013
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: Muhua Yang, Joseph T. Nickels, JR., Weidong Liu, Christina Ann Pellicane